Literature DB >> 21399757

Ribonucleases endowed with specific toxicity for spermatogenic layers.

Josef Matoušek1, Jin-Soo Kim, Josef Souček, Jan Rìha, Marc Ribó, Peter A Leland, Ronald T Raines.   

Abstract

Bovine seminal ribonuclease (BS-RNase) is a dimer in which the subunits are cross-linked by disulfide bonds between Cys31 of one subunit and Cys32 of the other. Dimeric BS-RNase is resistant to ribonuclease inhibitor (RI), a protein endogenous to mammalian cells, and is toxic to a variety of cell types. Monomeric BS-RNase (like its homolog, RNase A) is bound tightly by RI and is not cytotoxic. The three-dimensional structure of the RI·RNase A complex suggests that carboxymethylation of C32S BS-RNase (to give MCM31) or C31S BS-RNase (MCM32) could diminish affinity for RI. We find that MCM31 and MCM32 are not only resistant to RI, but are also aspermatogenic to mice. In contrast to the aspermatogenic activity of dimeric BS-RNase, that of MCM31 and MCM32 is directed only at spermatogenic layers. Intratesticular injection of MCM31 or MCM32 affects neither the diameter of seminiferous tubules nor the weight of testes. Also in contrast to wild-type BS-RNase, MCM31 and MCM32 are not toxic to other cell types. Direct immunofluorescence reveals that MCM31 and MCM32 bind only to spermatogonia and primary spermatocytes. This cell specificity makes MCM31 and MCM32 of potential use in seminoma therapy and contraception.

Entities:  

Year:  1997        PMID: 21399757      PMCID: PMC3055560          DOI: 10.1016/S0305-0491(97)00278-2

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  46 in total

1.  New and cryptic biological messages from RNases.

Authors:  G D'Alessio
Journal:  Trends Cell Biol       Date:  1993-04       Impact factor: 20.808

2.  A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis.

Authors:  J W Harper; B L Vallee
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

3.  The antitumor action of seminal ribonuclease and its quaternary conformations.

Authors:  V Cafaro; C De Lorenzo; R Piccoli; A Bracale; M R Mastronicola; A Di Donato; G D'Alessio
Journal:  FEBS Lett       Date:  1995-02-06       Impact factor: 4.124

4.  The effect of bull seminal ribonuclease on reproductive organs and sexual behaviour in male rats.

Authors:  Z Hlinák; J Matousek; J Madlafousek
Journal:  Physiol Bohemoslov       Date:  1981

5.  Bovine seminal ribonuclease produced from a synthetic gene.

Authors:  J S Kim; R T Raines
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

6.  A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.

Authors:  Y Wu; S M Mikulski; W Ardelt; S M Rybak; R J Youle
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

Review 7.  Spermatocytic seminoma.

Authors:  J N Eble
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

8.  Effect of ribonucleases on cell-mediated lympholysis reaction and on GM-CFC colonies in bone marrow culture.

Authors:  J Soucek; V Chudomel; I Potmĕsilová; J T Novák
Journal:  Nat Immun Cell Growth Regul       Date:  1986

9.  Structural basis for the biological activities of bovine seminal ribonuclease.

Authors:  J S Kim; J Soucek; J Matousek; R T Raines
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

10.  Energetics of catalysis by ribonucleases: fate of the 2',3'-cyclic phosphodiester intermediate.

Authors:  J E Thompson; F D Venegas; R T Raines
Journal:  Biochemistry       Date:  1994-06-14       Impact factor: 3.162

View more
  2 in total

1.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 2.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.